José L. Boyer - Concepedia

Author

José L. Boyer

University of North Carolina at Chapel Hill

Also Known As

Boyer, José L., Der, Channing, Fischer, Bilha, González, Alfonso, Graber, Stephen G, Harden, T. Kendall, J BOYER, J Boyer, J L Boyer, J. BOYER

141

Publications

7.2K

Citations

H-Index

Concepts

All Affiliations

University of North Carolina at Chapel Hill National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health Inspire Institute Bar-Ilan University

About

José L. Boyer is an author at University of North Carolina at Chapel Hill specializing in medicine, pharmacology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	27	1.9K
2	Natural Sciences	12	13	1.2K
3	Health Sciences	4	4	108
4	Allergy	1	1	24
5	Anatomy	1	1	27

José L. Boyer

Publications

Citations

H-Index

Page 1

	Year	Citations
Second messenger cascade specificity and pharmacological selectivity of the human P<sub>2Y1</sub>‐purinoceptor Joel B. Schachter, Qing Li, José L. Boyer, British Journal of Pharmacology Amino AcidsCellular PhysiologyMolecular PharmacologyNeuroendocrine MechanismCell Signaling	1996	251
Identification of competitive antagonists of the P2Y1 receptor. José L. Boyer, T Romero-Avila, Julieta Schachter, Molecular Pharmacology	1996	250
Kinetics of Activation of Phospholipase C by P2Y Purinergic Receptor Agonists and Guanine Nucleotides José L. Boyer, C. Peter Downes, T K Harden Journal of Biological Chemistry Proteinlipid InteractionCellular PharmacologyCellular PhysiologyMolecular PharmacologyMembrane Transport	1989	205
Beta gamma-subunit activation of G-protein-regulated phospholipase C. José L. Boyer, Gary L. Waldo, T K Harden Journal of Biological Chemistry Cellular PhysiologyPhospholipid VesiclesCell SignalingProtein FunctionMolecular Physiology	1992	198
Competitive and selective antagonism of P2Y<sub>1</sub> receptors by <i>N</i><sup>6</sup>‐methyl 2′‐deoxyadenosine 3′,5′‐bisphosphate José L. Boyer, Arvind Mohanram, Emidio Camaioni, British Journal of Pharmacology	1998	197
Expression of a cloned P2Y purinergic receptor that couples to phospholipase C. Theresa M. Filtz, Q Li, José L. Boyer, Molecular Pharmacology	1994	180
Agonist Action of Adenosine Triphosphates at the Human P2Y1 Receptor R. Kyle Palmer, José L. Boyer, Joel B. Schachter, Molecular Pharmacology	1998	163
Pharmacology of INS37217 [P1-(Uridine 5′)-P4- (2′-deoxycytidine 5′)tetraphosphate, Tetrasodium Salt], a Next-Generation P2Y2 Receptor Agonist for the Treatment of Cystic Fibrosis Benjamin R. Yerxa, Juan Sabater, C. William Davis, Journal of Pharmacology and Experimental Therapeutics	2002	149
Human P2Y<sub>1</sub>Receptor: Molecular Modeling and Site-Directed Mutagenesis as Tools To Identify Agonist and Antagonist Recognition Sites Stefano Moro, Danping Guo, Emidio Camaioni, Journal of Medicinal Chemistry	1998	145
Differential effects of P<sub>2</sub>‐purinoceptor antagonists on phospholipase C‐ and adenylyl cyclase‐coupled P<sub>2Y</sub>‐purinoceptors José L. Boyer, Irene E. Zohn, Kenneth A. Jacobson, British Journal of Pharmacology Reactive Blue 2Competitive AntagonistCellular PharmacologyPharmacotherapyExperimental Pharmacology	1994	142

Page 1